Fact CheckerSign in

NCT04798079Active, not recruiting

Systems Biology of Early Atopy

Source: ClinicalTrials.gov · Last updated 27 May 2026

Brief summary (registry, in English)

The goal of this study is to establish a birth cohort that collects prenatal and early life biosamples and environmental samples and rigorously phenotypes young children for food allergy and Atopic Dermatitis (AD) to identify prenatal and early life markers of high risk for food allergy and AD, as well as biological pathways (endotypes) that result in these conditions. Primary Objectives: * To study the role and interrelationships of established and novel clinical, environmental, biological, and genetic prenatal and early-life factors in the development and course of allergic diseases through age 3 years (or 6 years for those who choose to continue participation into SUNBEAM II), with an emphasis on atopic dermatitis and food allergy * To apply systems biology to identify mechanisms and biomarkers underlying the development of food allergy, atopic dermatitis, and their endotypes * To collect, process, and assay or store environmental and biological samples for current and future use in the study of allergic disease development

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
2500 (estimated)
First submitted
5 Mar 2021
Start date
18 Mar 2021
Primary completion date
Jul 2032
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NCT number
NCT04798079

What you commit to

  • Study type: Observational
  • Planned participants: 2500
  • From 18 Mar 2021 to the primary completion date, Jul 2032
  • 13 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Serious pregnancy complication (in the judgement of the investigator) prior to enrollment

Other illness

  • Born with a significant birth defect or medical condition, and in the judgment of the investigators, participation is not in the infant's best interest
    • Biological Father-
    • 1\. Biological fathers who are unable or unwilling to comply with the study protocol as it pertains to the biological father's participation are not eligible for enrollment
    • ----Note Regarding Legal Guardians who are not the Biological Parents:

Other

  • Pregnant Women-
  • Pregnant women who meet any of these criteria are not eligible for enrollment:
  • Inability or unwillingness to comply with study protocol
  • Fetus has a major chromosomal anomaly
  • Plans to move and would not be available for in-person visits at a study site
  • Plans to give up her child for adoption at birth
  • Pregnancy is the result of an egg donation
    • Infants-
    • Infants who meet any of these criteria are not eligible for enrollment:
  • Delivered earlier than 34 weeks of gestation
  • Sibling already enrolled
  • At screening for enrollment of either the mother or the child, if the biological mother intends to give the infant up for adoption, neither the mother nor the child are eligible for enrollment
  • If the biological mother gives up legal guardianship of the child during the child's follow-up period, the child may remain enrolled as long as the new legal guardian:
    • Agrees to meet the child's study requirements, and
    • Provides written informed consent for the child's continued participation.
  • Throughout the protocol where it refers to the mother, father, or parent answering questionnaires about the child or collecting samples from the child and the child's primary home, the legal guardian who provides consent for the child's participation may complete those procedures

Who the study is looking for

  • Pregnant Women-
  • Pregnant women who meet all of the following criteria are eligible for enrollment as study participants:
  • Age 18 years or older
  • Able to understand the oral and written instructions associated with study visits and procedures and provide informed consent
  • Pregnant at any stage
  • Planning to give birth at a study-site designated center
  • Agrees to enroll offspring into the study at birth
  • In the case of multiple gestation, agrees to enroll only one child who will be selected by randomized birth order
    • Biological Fathers-
    • Biological fathers who meet all of the following criteria are eligible for enrollment as study participants:
  • Age 18 years or older
  • Able to understand the oral and written instructions associated with study visits and procedures and provide informed consent

Age in the registry: 0 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (13)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins Children's Center, Department of Allergy & Immunology
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status
Massachusetts General Hospital, Translational and Clinical Research Center
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology
Coordinator of this site? Confirm its status
Chapel HillUnited StatesUnknown status
Northwestern University Feinberg School of Medicine: Dept of Dermatology
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status
Cincinnati Children's Hospital Medical Center
Coordinator of this site? Confirm its status
CincinnatiUnited StatesUnknown status
National Jewish Health
Coordinator of this site? Confirm its status
DenverUnited StatesUnknown status
Henry Ford Health System, Division of Allergy and Immunology
Coordinator of this site? Confirm its status
DetroitUnited StatesUnknown status
Texas Children's Hospital
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status
Arkansas Children's Hospital
Coordinator of this site? Confirm its status
Little RockUnited StatesUnknown status
University of Wisconsin School of Medicine and Public Health
Coordinator of this site? Confirm its status
MadisonUnited StatesUnknown status
Vanderbilt University Medical Center Department of Pediatrics Division of Pediatric Allergy, Immunology, and Pulmonary Medicine
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status
Kravis Children's Hospital, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
Sean N. Parker Center for Allergy & Asthma Research at Stanford University
Coordinator of this site? Confirm its status
StanfordUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.